The pharmaceutical unit dose packaging market is poised for substantial growth, projected to reach a value of $34.2 billion in 2023 and an impressive $136 billion by 2033, reflecting a remarkable compound annual growth rate (CAGR) of 14.8%.
This expansion is primarily driven by the escalating importance placed on product traceability and safety within the pharmaceutical industry. The growing awareness of drug tampering and contamination risks has led to an increased demand for packaging solutions that can safeguard medications from such dangers. Advanced technologies like e-pedigree systems, enabling drug tracking throughout the supply chain, have bolstered medication legitimacy and safety.
The availability of active pharmaceutical ingredients (APIs) also plays a significant role in driving the growth of blister-based unit dose packaging. The market has benefited from improved production and development facilities, as well as increased access to APIs.
Furthermore, the need for elder and child-resistant packaging has further fueled the demand for unit dose packaging. These packaging solutions enhance patient safety and reduce the risk of medication errors by preventing accidental ingestion by children and senior citizens. Additionally, the rising consumption of prescription medications, accompanied by increased income levels, contributes to market growth.
The rising global spending on medicines, especially in developed countries with improved healthcare practices and standards, including medicine quality, is expected to propel market expansion.
Moreover, the growing rates of drug consumption and the evolution of e-commerce platforms have also contributed to the increased demand for pharmaceutical unit dose packaging. E-commerce platforms offer simplified access to medications while adhering to strict regulations for safe logistics.
Gain Competitive Insights – View Our PDF Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5236
Key Takeaways:
- North America is projected to dominate the industry, accumulating over 38.6% revenue share by the end of the forecast period.
- The market in India is expected to witness the fastest CAGR of 7.90% during the forecast period.
- China is projected to exhibit a CAGR of 6.90% in the pharmaceutical unit dose packaging market.
- Vials are expected to account for 35% market share by the end of the forecast period in terms of packaging type.
- Plastic is anticipated to lead the market in terms of material type, with a 47.9% revenue share in 2023
“A surge in demand for over-the-counter drugs will especially create a favorable ground for pharmaceutical packaging materials. In addition, increasing preference for single-dose packaging formats, and rapid expansion of e-Pharmacy will further propel growth in the market”- comments an FMI Analyst
Competitive Landscape
The Pharmaceutical Unit Dose Packaging market is extremely competitive and consists of numerous key industry players. These players are innovating new products in the respiratory devices domain. This is expected to propel the pharmaceutical unit dose packaging market. The key industry players are:
Gerresheimer AG, West Pharmaceuticals Services, Inc, Schott AG, SGD SA, Stevanato Group S.p.a., Klockner Pentaplast Group, UDG Healthcare plc., Nipro Corporation, Amcor plc., Adelphi Healthcare Packaging, Winpak Ltd., Berry Global, Inc., Comar LLC, Constantia Flexibles Group GmbH, Catalent Inc., Becton, Dickinson and Company, Pacific Vial Manufacturing Inc., Sonoco Products Company, WestRock Company, AptarGroup, Inc.
Key market players are leveraging on inorganic growth strategies like acquisition, mergers, partnerships, and collaboration in order to enhance their product portfolio. This is expected to fuel the global Pharmaceutical Unit Dose Packaging Market.
- In May 2021, ‘Gerresheimer’ showcased a new platform for on body infusion pump “SensAIR” that can deliver drugs of high viscosity. It is simple to use and helps in the self-determination of medication.
- In January 2022, ‘Berry Global Group’ and ‘Raw Elements USA’ collaborated to introduce a sugarcane-based sustainable tube. The tubes are manufactured from waste sugarcane, which is converted into high-density polyethylene and low-density polyethylene to make a material with the same chemical composition as polyethylene obtained from fossil fuels.
- In June 2021, Amcor PLC introduced the ‘ACT2100’ heat seal coating for use with medical-grade DuPont Tyvek2 and paper packaging. This innovative coating process enhances the performance characteristics of medical applications.
More Valuable Insights Available
Future Market Insights offers an unbiased analysis of the global pharmaceutical unit dose packaging market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.
To understand opportunities in the pharmaceutical unit dose packaging market, the market is segmented on the basis of product, material, end-use, and regions.
Regional Outlook:
North America: Strong Growth Prospects with Dominance in the Market
North America is poised for significant growth in the pharmaceutical packaging market. With a revenue share of 21.2% in 2022, the region is expected to expand its market share to over 38.6% by the end of the forecast period. The presence of leading manufacturers, including Gerresheimer AG, AptarGroup Inc., Amcor Ltd., and Berry Plastics Group, Inc., contributes to the increasing demand for single-dose pharmaceutical bottles. Thriving economies, a growing geriatric population, advanced medical delivery systems, and a strong healthcare sector further bolster the region’s growth prospects. The United States, accounting for 11.90% of revenue share in 2022, is expected to capture a 12.8% market share by the end of 2023.
China: Driving Growth with a Strong CAGR
China’s pharmaceutical packaging market is projected to experience significant growth, with a compound annual growth rate (CAGR) of 6.9% throughout the forecast period. The region’s increasing health awareness among consumers, coupled with rising disposable income levels, is expected to boost the pharmaceutical industry and drive demand for unit-dose pharmaceutical packaging. China dominates the Asia Pacific regional market and is poised to maintain this trend due to factors such as government initiatives like Healthy China 2020, increasing contract-manufacturing activities, and a growing aging population
Key Insights oF The Report
- Key Trends in the Pharmaceutical Unit Dose Packaging Market
- New Advancements in Production Technologies
- New Product Launches, Expansions of Pharmaceutical Unit Dose Packaging Market
Ready to Scale Up? Request Your Custom Report: https://www.futuremarketinsights.com/customization-available/rep-gb-5236
Key Segments Profiled in the Pharmaceutical Unit Dose Packaging Industry Survey
By Product:
- Blisters
- Ampoules
- Vials
- Prefilled Syringes & Cartridges
By Material:
- Plastic
- Polyethylene
- Polypropylene
- Polyvinyl Chloride
- Polyethylene Terephthalate
- Aluminium
- Glass
- Paper & Paperboard
By End Use:
- Ophthalmic
- Injectable
- Biologics
- Wound Care
- Respiratory Therapy
- Orals
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
About FMI
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
LinkedIn| Twitter| Blogs
